Initial studies of vascular cell adhesion molecule-1 (VCAM-) focused on its role in endothelial-leukocyte interactions ( 1, 2) . A member of the immunoglobulin gene superfamily, this transmembrane protein on the surface of endothelial cells interacts with the f,3 integrin very late antigen-4 expressed by mononuclear leukocytes (3) . In the context of atherosclerosis, this molecule warrants particular interest because of its early and focal expression on endothelial cells just where monocytes first accumulate at the sites of fatty streak formation (4, 5) .
The case of VCAM-1 illustrates a general principal that the restriction of expression of a molecule decreases as a function of time that the molecule is studied. Early surveys disclosed VCAM-1 expression not only on endothelium but on follicular dendritic cells in lymph nodes (6) . Others reported VCAM-1 expression on skeletal muscle cells and postulated a role for this molecule in myogenesis (7) . Elsewhere in this issue, O'Brien et al. report that in human atheroma not only endothelial cells, but certain lesional macrophages and smooth muscle cells also express VCAM-1 (8 
Activation of intimal smooth muscle cells during atherogenesis
Regardless of its functional consequences, the finding of VCAM-1 in advanced human atherosclerotic plaques and in the maturing experimental atheroma serve as a marker of "activation" of smooth muscle cells. The concept of "phenotypic modulation" of smooth muscle cells during atherogenesis gained currency some years ago ( 15) . The original concept that intimal smooth muscle cells in the atherosclerotic plaque differ from those in the normal tunica media has proven a valuable paradigm over the years. The nomenclature that describes the intimal smooth muscle cells as "synthetic" and the normal medial smooth muscle cells as "contractile" seems less helpful as few actually measure biosynthetic or contractile function when using these terms.
The increasing availability of specific molecular markers permits a more precise definition of the "activated" smooth muscle cell found in the arterial intima during atherosclerosis. Smooth muscle cells in regions of the atherosclerotic plaque express class II histocompatibility antigens, cell surface molecules required for antigen presentation to helper T cells ( 16) . Many cells within the atherosclerotic intima express intercellular adhesion molecule-1, a member of the immunoglobulin superfamily that may also participate in retention ofleukocytes ( 17, 18) . Compared with normal medial smooth muscle cells, those in the atherosclerotic intima display increased levels of the complement regulatory decay accelerating factor ( 19) , and genes for certain growth-promoting molecules, including isoforms of platelet-derived growth factor (20) 
